NIH shares data on Alzheimer's biomarkers

The NIH is sharing data from a proteomics study launched to identify new plasma-based biomarkers for Alzheimer's disease. The study, the first in a multi-phase program, was undertaken by a team of experts drawn from academia, industry and the government. Story